The concentrations of FGF-21 were elevated in individuals diagnosed with metabolic syndrome (335.80 pg/mL [IQR = 206.22–488] compared to 166.32 pg/mL [IQR = 135.70–256.61], p < 0.001). This evidence concerns the gene FGF21 and metabolic syndrome.